Woodline Partners LP Has $22.15 Million Stake in Masimo Corporation $MASI

Key Points

• Woodline Partners LP increased its stake in Masimo Corporation by 159.8% to a total of 132,969 shares, valued at over $22 million.
• Insider transactions include Director William R. Jellison purchasing 3,000 shares at an average price of $145.98, marking a 167.60% increase in his position.
• Masimo has received positive feedback from analysts, with Zacks Research upgrading the stock to a "strong-buy" rating and Piper Sandler raising the target price to $210.

Woodline Partners LP grew its holdings in shares of Masimo Corporation (NASDAQ:MASI - Free Report) by 159.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 132,969 shares of the medical equipment provider's stock after acquiring an additional 81,784 shares during the period. Woodline Partners LP owned 0.25% of Masimo worth $22,153,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Twin Tree Management LP bought a new stake in shares of Masimo during the 1st quarter valued at about $29,000. Farther Finance Advisors LLC lifted its stake in Masimo by 128.9% in the first quarter. Farther Finance Advisors LLC now owns 206 shares of the medical equipment provider's stock valued at $35,000 after buying an additional 116 shares during the period. NBC Securities Inc. acquired a new position in Masimo in the first quarter valued at approximately $61,000. UMB Bank n.a. boosted its holdings in shares of Masimo by 134.0% during the 1st quarter. UMB Bank n.a. now owns 447 shares of the medical equipment provider's stock worth $74,000 after buying an additional 256 shares in the last quarter. Finally, Quarry LP grew its position in shares of Masimo by 253.5% during the 1st quarter. Quarry LP now owns 449 shares of the medical equipment provider's stock worth $75,000 after buying an additional 322 shares during the period. 85.96% of the stock is owned by institutional investors.

Insider Transactions at Masimo

In other news, Director William R. Jellison bought 3,000 shares of Masimo stock in a transaction dated Monday, August 11th. The stock was purchased at an average price of $145.98 per share, for a total transaction of $437,940.00. Following the purchase, the director directly owned 4,790 shares in the company, valued at $699,244.20. The trade was a 167.60% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 9.70% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on MASI. Zacks Research upgraded shares of Masimo from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, September 3rd. BTIG Research reiterated a "buy" rating on shares of Masimo in a report on Thursday, August 14th. Piper Sandler raised their target price on Masimo from $200.00 to $210.00 and gave the company an "overweight" rating in a research note on Wednesday, August 6th. Finally, Wall Street Zen downgraded Masimo from a "buy" rating to a "hold" rating in a research note on Friday, May 30th. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average price target of $193.60.

Masimo Price Performance

Shares of NASDAQ MASI opened at $145.82 on Thursday. The stock has a market cap of $7.92 billion, a price-to-earnings ratio of -17.12 and a beta of 1.23. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.61 and a current ratio of 2.14. Masimo Corporation has a fifty-two week low of $111.03 and a fifty-two week high of $194.88. The firm's 50-day simple moving average is $153.09 and its 200 day simple moving average is $159.81.

Masimo (NASDAQ:MASI - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The medical equipment provider reported $1.33 EPS for the quarter, topping analysts' consensus estimates of $1.22 by $0.11. Masimo had a positive return on equity of 26.54% and a negative net margin of 24.85%.The firm had revenue of $370.90 million during the quarter, compared to analyst estimates of $368.65 million. During the same period in the previous year, the company posted $0.86 EPS. The company's revenue for the quarter was up 7.7% on a year-over-year basis. As a group, research analysts anticipate that Masimo Corporation will post 4.1 earnings per share for the current fiscal year.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.